Edgewise Therapeutics, Inc. (EWTX)

SEC filing

Edgewise Therapeutics, Inc.

EWTX · CIK 1710072

4 · Aug 14, 2026 · Director, Chief Scientific Officer Russell Alan J sold 5,901 shares at $43.73/share ($258.0K); exercised options for 25.62K shares; was granted 97.50K shares

Director, Chief Scientific Officer Russell Alan J sold 5,901 shares at $43.73/share ($258.0K); exercised options for 25.62K shares; was granted 97.50K shares

Filed: Aug 14, 2026
Period: Aug 12, 2026
Accession: 0001853529-26-000002
Filer: Edgewise Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTprimarydocument.xml
Open SEC.gov